How can you measure a person's quality of life? For columnist Patrick Moeschen, the key is deciding for yourself what a good ...

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we are going to take a look at ...

The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts disc ...

Sarepta Therapeutics SRPT announced that it has completed enrolment and dosing in the phase III EMERGENE study evaluating its ...

Therapeutics announced that enrollment and dosing is complete in EMERGENE or Study SRP-9003-301 , a Phase 3 clinical trial of ...

We have picked three biotech stocks with promising gene therapies in their portfolios/pipelines that are likely to perform ...

The Muscular Dystrophy Association (MDA) and Coalition to Cure Calpain 3 (C3) announced today collaborative funding of a $300,000 research grant to ...

Research Grants and 7 Development Awards for Fellowship Trainees Will Fund Critical Research Across Multiple Neuromuscular ...

Patidistrogene bexoparvovec is a gene therapy commercialized by Sarepta Therapeutics, with a leading Phase II program in Limb-Girdle Muscular Dystrophy.

Ribitol (BBP-418) is under development for the treatment of limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). It acts by restoring glycosylate alpha- dystroglycan (aDG) substrate. It is an oral ...

His coaches sent him to get checked out. Gabriel Vergara, who lives with muscular dystrophy, shown outside his apartment in Hialeah. MATIAS J. OCNER [email protected] After a blur of tests ...